-
A recent review of the literature evaluating methods to decrease preterm birth in twins has shown little or no benefit of bed rest, cerclage, or 17 alpha-hydroxy progesterone.
-
-
In this retrospective, cohort study, a see-and-treat protocol resulted in only a 4.5% overtreatment rate.
-
Infants of women initiating either a combined oral contraceptive, the levonorgestrel IUS, the etonogestrel implant, or a copper IUD at 42 days postpartum ingested similar volumes of breast milk and displayed similar growth.
-
An 11-year prospective screening trial in 4051 menopausal women (age 50-74).
-
Evidence-based updates in primary care medicine By Louis Kuritzky, MD
Supplement to Clinical Cardiology Alert, Clinical Oncology Alert, Critical Care Alert, Hospital Medicine Alert, Infectious Disease Alert, Neurology Alert, OB/GYN Clinical Alert, Primary Care Reports.
-
Just-released results from international trials indicate a potential vaccine, designed to protect against nine HPV strains, might be the next step in cervical cancer protection. In the pivotal Phase III efficacy study, the investigational 9-valent HPV vaccine prevented approximately 97% of cervical, vaginal, and vulvar pre-cancers caused by HPV types 31, 33, 45, 52, and 58.
-
Make the first reproductive health visit for a young teen a successful one by using the HEEADSSS (Home environment, Education and employment, Eating, peer-related Activities, Drugs, Sexuality, Suicide/depression, and Safety from injury and violence) method of interviewing in performing a psychosocial review of systems.
-
More women are now choosing long-acting reversible contraceptive (LARC) methods, such as intrauterine devices (IUDs) and the subdermal contraceptive implant. The number of women using LARC methods rose from 2.4% in 2002 to 8.5% in 2009.
-
In a national study, menstrual disorders accounted for 19.1% of 20.1 million physician office visits for gynecologic conditions over two years.